Swiss drug giant Novartis has announced the launch of two new joint working projects with national Cancer Vanguard sites, which aim to determine novel ways of boosting patient care pathways and access to services.
21st March 2018
Alzheimer’s Research UK is calling on the NHS and the pharma industry to join its new taskforce to ensure people with dementia can access future treatments without unnecessary delay.
21st March 2018
New research shows that more than three million primary care hours are spent on skin conditions, at a cost to the NHS of £723 million each year.
21st March 2018
The National Institute for Health Research (NIHR) has launched a new set of national standards for public involvement in clinical research for use by organisations across the UK.
21st March 2018
Cost regulators for NHS therapies in England and Wales have published draft guidelines rejecting funding for Dompé’s cenegermin as a treatment for neurotrophic keratitis, a rare eye condition.
20th March 2018
Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients in type I diabetes.
20th March 2018
Napp Pharmaceuticals has secured itself exclusive UK distribution rights to Celltrion Healthcare’s Herceptin biosimilar Herzuma.
20th March 2018
MPs are calling on NHS England and Vertex to come to an agreement over the price of cystic fibrosis drug Orkambi.
20th March 2018
NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal College of Emergency Medicine’s Winter Flow Project.
19th March 2018
Coeliac UK has launched a new research fund and fundraising appeal that aims to raise £5 million to improve understanding and management of coeliac disease and gluten related autoimmune conditions.
19th March 2018
Lundbeck has announced plans to buy Prexton Therapeutics in a deal valued at up to 905 million euros.
19th March 2018
US regulators have cleared CSL Behring’s Hizentra for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder affecting the peripheral nerves that can cause permanent nerve damage.
19th March 2018
Clinical researchers in the Americas have submitted their essays for this year's competition and yesterday, the authors and finalists were revealed at a meeting of the executive steering group.
16th March 2018
The number of medicines prescribed on the NHS in England increased in 2017 but their net ingredient cost took a downturn, according to data released by NHS Digital.
16th March 2018
PharmaTimes International Clinical Researcher of the Year – one of the most important dates in the clinical research calendar - will take place on 17 May at the Millennium Gloucester Hotel in the heart of London’s Kensington.
16th March 2018
